Founded in 2004, Canbex Therapeutics, classified under reg no. 05073720 is an active company. Currently registered at 2 Royal College Street NW1 0NH, London the company has been in the business for twenty years. Its financial year was closed on 31st July and its latest financial statement was filed on July 31, 2022. Since June 30, 2005 Canbex Therapeutics Limited is no longer carrying the name Aximygen.
The company has one director. Jesse S., appointed on 1 March 2013. There are currently no secretaries appointed. At present there are several former directors listed by the company. In addition, the company lists several former secretaries. The full list of both former directors and former secretaries might be found in the box below.
Office Address | 2 Royal College Street |
Town | London |
Post code | NW1 0NH |
Country of origin | United Kingdom |
Registration Number | 05073720 |
Date of Incorporation | Mon, 15th Mar 2004 |
Industry | Other research and experimental development on natural sciences and engineering |
End of financial Year | 31st July |
Company age | 20 years old |
Account next due date | Tue, 30th Apr 2024 (1 day after) |
Account last made up date | Sun, 31st Jul 2022 |
Next confirmation statement due date | Fri, 29th Mar 2024 (2024-03-29) |
Last confirmation statement dated | Wed, 15th Mar 2023 |
The list of PSCs that own or control the company is made up of 3 names. As BizStats researched, there is Jesse S. This PSC has 75,01-100% voting rights and has 75,01-100% shares. Another one in the persons with significant control register is Rusbio Ventures Limited Partnership that put Moscow, Russia as the address. This PSC has a legal form of "a partnership", owns 75,01-100% shares, has 75,01-100% voting rights. This PSC owns 75,01-100% shares and has 75,01-100% voting rights. Then there is The Wellcome Trust Ltd, who also meets the Companies House requirements to be indexed as a PSC. This PSC has a legal form of "a private limited company", owns 25-50% shares, has 25-50% voting rights. This PSC , owns 25-50% shares and has 25-50% voting rights.
Jesse S.
Notified on | 28 November 2019 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Rusbio Ventures Limited Partnership
Office 1206 12 Krasnopresnenskaya Emb., Moscow, Russia
Legal authority | Russian |
Legal form | Partnership |
Notified on | 16 July 2019 |
Ceased on | 28 November 2019 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
The Wellcome Trust Ltd
Gibbs Building 215 Euston Road, London, NW1 2BE, England
Legal authority | England And Wales |
Legal form | Private Limited Company |
Country registered | United Kingdom |
Place registered | Uk Companies House |
Registration number | 02711000 |
Notified on | 6 April 2016 |
Ceased on | 16 July 2019 |
Nature of control: |
25-50% voting rights 25-50% shares |
Aximygen | June 30, 2005 |
Profit & Loss | ||||||
---|---|---|---|---|---|---|
Accounts Information Date | 2018-07-31 | 2019-07-31 | 2020-07-31 | 2021-07-31 | 2022-07-31 | 2023-07-31 |
Balance Sheet | ||||||
Cash Bank On Hand | 457 882 | 513 614 | ||||
Current Assets | 1 044 018 | 607 875 | 42 213 | 21 342 | 4 212 | 8 |
Debtors | 586 136 | 94 261 | ||||
Net Assets Liabilities | 610 031 | 603 876 | 35 957 | 16 407 | 2 962 | 1 110 |
Other | ||||||
Average Number Employees During Period | 5 | 2 | 1 | 1 | ||
Balances Amounts Owed To Related Parties | 64 381 | |||||
Creditors | 433 987 | 3 999 | 6 257 | 4 935 | 5 250 | |
Net Current Assets Liabilities | 610 031 | 603 876 | 42 213 | 21 342 | 8 212 | 1 110 |
Prepayments Accrued Income Not Expressed Within Current Asset Subtotal | 4 000 | 1 102 | ||||
Total Assets Less Current Liabilities | 610 031 | 603 876 | 42 213 | 21 342 | 8 212 | 1 110 |
Provisions For Liabilities Balance Sheet Subtotal | 6 256 |
Type | Category | Free download | |
---|---|---|---|
AA |
Micro company financial statements for the year ending on July 31, 2022 filed on: 27th, April 2023 |
accounts | Free Download (3 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy